One often-overlooked cause is pseudocholinesterase deficiency (PD), a genetic or acquired condition in which a deficiency or malfunction of the pseudocholinesterase enzyme (also known as butyrylcholinesterase or plasma cholinesterase) slows the breakdown of certain medications. This evidence concerns the gene BCHE and butyrylcholinesterase deficiency.